In addition, the research on T-cell showed that co-expression of PD-1, LAG-3 and TIM-3 was associated with prominent activation (CD69 expression) and effector function (GZMB level), as well as elevated levels of proapoptotic markers in non-small cell lung cancer [47]. This evidence concerns the gene CD69 and non-small cell lung carcinoma.